Fact-checks

All-In Podcast fact-checks: the claims behind the argument, checked against the record

We have checked 82 claims from 6 All-In Podcast episodes against primary sources. Every source is linked and dated, and every verdict is about the claim, not the person.

Latest fact-checks

All-In Podcast · Episode 292 · aired October 10, 2026

All-In #292 fact-check: 12 of 14 claims hold up. One doesn't.

12 of 14 claims hold up. AI-linked investment added 0.5 to 1.4 points to US growth this year, not 3, and the Anthropic odds were personal estimates.

14 claims checked 12 hold up 1 needs context 1 doesn't hold up
All-In Podcast · Episode 291 · aired October 2, 2026

All-In #291 fact-check: most of the figures check out. The framing often doesn't.

Seven of 14 claims hold up. Two large figures do not: the middle class's share of U.S. wealth, and inflation under Trump.

14 claims checked 7 hold up 4 need context 3 don't hold up
All-In Podcast · Episode 290 · aired September 26, 2026

All-In #290 fact-check: 11 of 14 claims hold up. Two don't.

11 of 14 claims hold up. Anthropic cut its token prices by 20%, not by half, and the $45 trillion COVID-19 cost has no source.

14 claims checked 11 hold up 1 needs context 2 don't hold up
All-In Podcast · Episode 289 · aired September 11, 2026

All-In #289 fact-check: nine of 13 claims hold up. China builds nuclear power for about $2.6 billion a gigawatt, not $1 billion.

Nine of 13 claims hold up. Three don't: Coxon's time at Anthropic, who led its Series A, and China's nuclear costs.

13 claims checked 9 hold up 1 needs context 3 don't hold up
All-In Podcast · Episode 288 · aired September 4, 2026

All-In #288 fact-check: ten of 14 claims hold up, and three of the other four leave out what their own source says.

Ten of 14 claims hold up. In three of the other four, the cited report or study says more than the host did.

14 claims checked 10 hold up 4 need context 0 don't hold up
All-In Podcast · Episode 287 · aired August 29, 2026

All-In #287 fact-check: most of the figures hold up. Nvidia's valuation and a vaccine price don't.

Eight of 13 claims hold up. The two that don't are Nvidia's valuation and a $500,000 price for Moderna's cancer vaccine.

13 claims checked 8 hold up 3 need context 2 don't hold up

How we check

We take the claims that carry the argument and check each one against primary sources: the agency release, the filing, the original article. We link every source with its date. The speaker carries the burden of proof, so a claim with no evidence either way is rated Unsupported, not false. We check in both directions, and we say so when a speaker understated their own case.

Accurate
The claim is right as stated.
Mostly accurate
Right in substance, though a detail is off or out of date.
Missing context
The figure is right, but the frame around it leaves a false impression.
Misleading
Built from real data, but arranged to mean something the data does not show.
Inaccurate
Wrong: the record shows a different figure or fact.
Unsupported
We found no evidence for it, and none against it.

Every claim is checked against primary sources, and every verdict gets an independent second review before we publish. We use AI to research and draft, and no verdict rests on a model's memory: each one cites a source you can open. When a claim is about an AI company, a model made by that company does not get the final say.

Found an error? Email hello@truestandard.ai with the claim and your source. We log every correction on the page, with its date.